Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX STOCKHOLM  >  Probi AB (publ)    PROB   SE0001280355

PROBI AB (PUBL)

(PROB)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Omx Stockholm
09/21/2020 09/22/2020 09/23/2020 09/24/2020 09/25/2020 Date
356.5(c) 357(c) 361.5(c) 347(c) 342.5(c) Last
4 952 1 729 2 151 5 168 3 838 Volume
-2.60% +0.14% +1.26% -4.01% -1.30% Change
More quotes
Financials
Sales 2020 671 M 73,5 M 73,5 M
Net income 2020 92,0 M 10,1 M 10,1 M
Net cash position 2020 284 M 31,1 M 31,1 M
P/E ratio 2020 41,5x
Yield 2020 0,45%
Sales 2021 721 M 79,0 M 79,0 M
Net income 2021 113 M 12,4 M 12,4 M
Net cash position 2021 386 M 42,3 M 42,3 M
P/E ratio 2021 33,7x
Yield 2021 0,63%
Capitalization 3 902 M 427 M 428 M
EV / Sales 2020 5,40x
EV / Sales 2021 4,88x
Nbr of Employees -
Free-Float 38,9%
More Financials
Company
Probi AB is a Sweden-based company engaged in the probiotics research and development. The Company’s activities are divided into two business areas: Functional Foods, which focuses on the probiotics application in food in partnership with food companies; and Consumer Healthcares, which develops, commercializes and sells Probi probiotics in collaboration with a range of entities, such as pharmaceutical companies... 
More about the company
Notations Surperformance© of Probi AB (publ)
Trading Rating : Investor Rating :
More Ratings
All news about PROBI AB (PUBL)
08/27PROBI : New clinical results on stress from Probi and their probiotic strain L. ..
AQ
07/17Q2 2020 : Probi raises long-term financial targets
AQ
07/14PROBI PUBL : Presentation of Probi's Q2 report 2020 and new financial targets
PU
07/14PROBI PUBL : Presentation of Probi's Q2 report 2020 and new financial targets
AQ
07/02PROBI PUBL : and Örebro University to collaborate on research into exploration o..
AQ
05/14PROBI PUBL : A true pioneer in probiotic research is elected NutraChampion 2020
AQ
05/14PROBI AB (PUBL) : Ex-dividend day for final dividend
FA
05/13PROBI PUBL : ´s Annual General Meeting 2020
PU
05/13PROBI PUBL : Annual General Meeting 2020
AQ
04/24Q1 2020 : A solid start to the year
AQ
04/21PROBI PUBL : Presentation of Probi's Q1 report 2020
PU
04/21PROBI PUBL : Presentation of Probi's Q1 report 2020
AQ
04/08PROBI PUBL : publishes Annual and Sustainability Report for 2019
AQ
04/07PROBI PUBL : Notice to Annual General Meeting in Probi AB (publ)
AQ
03/24PROBI PUBL : and Viva5 announce strategic joint venture to address growing marke..
AQ
More news
News in other languages on PROBI AB (PUBL)
02/11PROBI AB (PUBL) : rentabilité renforcée
2019JPMorgan belässt Symrise auf 'Underweight' - Ziel 63 Euro
2018PROBI AB : Veröffentlichung des Halbjahresergebnisses
2018PROBI AB : publication des résultats semestriels
2018PROBI AB : Veröffentlichung des Jahresergebnisses
More news
Chart PROBI AB (PUBL)
Duration : Period :
Probi AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PROBI AB (PUBL)
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
 
Mean consensus -
Number of Analysts 2
Average target price 420,00 SEK
Last Close Price 342,50 SEK
Spread / Highest target 22,6%
Spread / Average Target 22,6%
Spread / Lowest Target 22,6%
EPS Revisions
Managers
NameTitle
Tom Juhani Rönnlund Chief Executive Officer
Jean-Yves Parisot Chairman
Andy McShea Vice President-Operations
Henrik Lundkvist Chief Financial Officer
Niklas Brandt Vice President-Information Technology
Sector and Competitors
1st jan.Capitalization (M$)
PROBI AB (PUBL)54.28%427
BY-HEALTH CO., LTD.26.76%4 785
BALCHEM CORPORATION-5.88%3 094
THE SIMPLY GOOD FOODS COMPANY-23.72%2 076
MEDIFAST, INC.50.48%1 931
JAMIESON WELLNESS INC.55.88%1 187